Scientists and administrators make bumbling spies no matter which side they’re on, it appears. A recent report from the New York Times details efforts by Food and Drug Administration (FDA) administrators to track the online activities of a group of five dissident scientists, all putatively to protect trade secrets of companies seeking FDA approval for breast and colon imaging devices. Unfortunately, the proprietary information was posted to the Web inadvertently as matters came to a head, remaining openly available until reporters started asking about it.
Perhaps showing how vindictive matters became, four of the five scientists were let go after their activities became known, and they are now suing the FDA.
The absurdity apparently started with concerns that information was being leaked out of the FDA by scientists voicing concerns about how certain devices were being evaluated. This led FDA officials to ask the Department of Health and Human Services’ inspector general to conduct a criminal probe. They were turned down. So, it was time for someone at the FDA to take matters into their own hands. Their next step was to buy SpectorSoft tracking software for a few hundred dollars, and install it on the scientists’ work computers.
SpectorSoft tracks keywords or phrases as they are typed into a computer, and captures emails and instant messages, as well as Web sites.
The scientists being tracked were raising concerns about how the FDA was evaluating radiographic devices used in mammography and colonoscopy. They had concerns that the radiation dangers were being shunted aside or downplayed. And they probably had a point — a confidential review by the Office of Special Council this past May found that the scientists’ medical concerns constituted “a substantial and specific danger to public safety.”
But that didn’t stop some at the FDA from trying to track what these scientists were doing, who they were talking to, and what they were saying — taking it so far as to capture letters to the President and emails from personal accounts to reporters.
Government officials have been shocked by the goings-on. The White House Office of Management and Budget issued a memo last month emphasizing that internal monitoring, while allowed, must be done in ways that “do not interfere with or chill employees’ use of appropriate channels to disclose wrongdoing.”
So, it seems overzealous administrators at the FDA have not been elegant spies — they’ve overstepped their bounds, done things without approval, crossed lines, and triggered lawsuits. And the scientists themselves were not exactly sophisticated, doing much of their whistle-blowing from work computers they knew could be monitored (although, to be fair, they probably had no inkling things might be taken this far).
And, in a charming additional bit of ironic glory, it seems an FDA contractor keeping the 80,000 pages of documents generated by the monitoring inadvertently released them online for all to see. When the documents went up isn’t clear, but they were taken down last Friday after reporters started asking about them.
When science and the public good is put aside for a paranoid hunt for “prime movers” and “ancillary actors” in an imagined bit of espionage, all in an effort to protect proprietary business interests, someone’s priorities have clearly gone awry. Maybe those colonoscopy imaging devices can help those involved find their way out.
- Lawmakers question FDA surveillance operation (cbsnews.com)